RCM
IQMDU

Rivernorth Capital Management’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Rivernorth Capital Management’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,000
Closed -$256K – 741
2022
Q4 		$256K Hold
25,000
– – 0.01% 422
2022
Q3 		$253K Hold
25,000
– – 0.01% 515
2022
Q2 		$251K Hold
25,000
– – 0.01% 503
2022
Q1 		$253K Hold
25,000
– – 0.01% 519
2021
Q4 		$255K Buy
+25,000
New +$253K 0.01% 443

Other funds holding IQMDU

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
BHWM
Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rivernorth Capital Management's IQMDU Position: Q1 2023 in Review

Rivernorth Capital Management sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2023, closing a stake of 25,000 shares — an estimated $256K sold.

Rivernorth Capital Management first reported a position in IQMDU in Q4 2021 and held it in 5 quarters. The position peaked at $256K in Q4 2022. 6 funds tracked by Wall St. Rank hold IQMDU as of Q1 2023.

  • Rivernorth Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
  • Rivernorth Capital Management sold 25,000 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2023, an estimated $256K.
  • Rivernorth Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 5 quarters.
  • Rivernorth Capital Management's Intelligent Medicine Acquisition Corp. Unit position peaked at $256K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2023.

Based on Rivernorth Capital Management's 13F filing for Q1 2023, filed 15 May 2023.